These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 6122835)
41. An unusual case of toe ulceration. Lankipalli R; Konkle B; Mohler ER Vasc Med; 2006 Feb; 11(1):35-7. PubMed ID: 16669411 [TBL] [Abstract][Full Text] [Related]
42. Thrombocytosis: age dependent aetiology and analysis of platelet indices for differential diagnosis. Syed NN; Usman M; Khurshid M Indian J Pathol Microbiol; 2007 Jul; 50(3):628-33. PubMed ID: 17883167 [TBL] [Abstract][Full Text] [Related]
43. Anagrelide: a new drug for treating thrombocytosis. Silverstein MN; Petitt RM; Solberg LA; Fleming JS; Knight RC; Schacter LP N Engl J Med; 1988 May; 318(20):1292-4. PubMed ID: 3362187 [TBL] [Abstract][Full Text] [Related]
44. [Development of acute coronary syndrome in three patients with essential thrombocythemia or polycythemia vera]. Tekin M; Gökaslan S; Diker E; Aydoğdu S Turk Kardiyol Dern Ars; 2008 Jan; 36(1):35-8. PubMed ID: 18453785 [TBL] [Abstract][Full Text] [Related]
48. Reduced platelet factor X-activating activity: a possible contribution to bleeding complications in polycythaemia vera and essential thrombocythaemia. Cortellazzo S; Colucci M; Barbui T; Dini E; Semeraro N Haemostasis; 1981; 10(1):37-50. PubMed ID: 7203175 [TBL] [Abstract][Full Text] [Related]
49. [Treatment of polycythemia vera]. Dulíček P Vnitr Lek; 2018; 64(10):955-960. PubMed ID: 30590943 [TBL] [Abstract][Full Text] [Related]
50. [Therapy with interferon (recombinant IFN-alpha-2C) in myeloproliferative diseases with severe thrombocytoses]. Linkesch W; Gisslinger H; Ludwig H; Flener R; Sinzinger H Acta Med Austriaca; 1985; 12(5):123-7. PubMed ID: 3914173 [TBL] [Abstract][Full Text] [Related]
51. Low incidence of familial occurrence of thrombocythaemia and/or thrombocytosis. Randi ML; Fabris F; Visentin I; Girolami A Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(5):695-9. PubMed ID: 2465250 [TBL] [Abstract][Full Text] [Related]
52. Risk of leukemic transformation in PV and ET patients. Chomienne C; Rain JD; Brière J; Pathol Biol (Paris); 2004 Jun; 52(5):289-93. PubMed ID: 15217716 [TBL] [Abstract][Full Text] [Related]
54. [Secondary or reactive thrombocytosis. Clinico-epidemiological significance apropos of a personal series of 385 cases]. Malamani GD; Agosta G; Grandi A; Tinelli C; Venco A Recenti Prog Med; 1988 Jan; 79(1):15-8. PubMed ID: 3375539 [No Abstract] [Full Text] [Related]
56. [Significance of platelet parameters and lactate dehydrogenase level in differential diagnosis for thrombocytosis]. Zhang KJ; Lu QY; Li P; Zhang P; Niu XQ Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Aug; 18(4):972-5. PubMed ID: 20723311 [TBL] [Abstract][Full Text] [Related]
57. Paraneoplastic thrombocytosis in breast cancer. Rajkumar A; Szallasi A Anticancer Res; 2013 Oct; 33(10):4545-6. PubMed ID: 24123028 [TBL] [Abstract][Full Text] [Related]
58. Heparin-associated thrombocytopenia in a patient with polycythemia vera: the importance of a marked drop in platelet count. Garcia S; Cervero A; Sanchez M; Colomina P Acta Haematol; 1991; 85(3):169-70. PubMed ID: 2042450 [TBL] [Abstract][Full Text] [Related]
59. Polycythemia and Thrombocytosis. Parnes A; Ravi A Prim Care; 2016 Dec; 43(4):589-605. PubMed ID: 27866579 [TBL] [Abstract][Full Text] [Related]